The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: Study protocol for a randomized controlled trial
Version 3 2024-06-17, 23:58
Version 2 2024-06-06, 01:52
Version 1 2017-05-11, 15:20
journal contribution
posted on 2024-06-17, 23:58 authored by A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, Michael BerkMichael Berk, Olivia DeanOlivia Dean, J McGrath, CW Group, J ScottThe efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: Study protocol for a randomized controlled trial
History
Journal
TrialsVolume
18Article number
ARTN 165Pagination
1 - 11Location
EnglandOpen access
- Yes
ISSN
1745-6215eISSN
1745-6215Language
EnglishPublication classification
C Journal article, C1 Refereed article in a scholarly journalCopyright notice
2017, The Author(s)Issue
1Publisher
BIOMED CENTRAL LTDUsage metrics
Categories
Keywords
Science & TechnologyLife Sciences & BiomedicineMedicine, Research & ExperimentalResearch & Experimental MedicineAdjuvantSodium benzoateEarly PsychosisSchizophreniaInterventionRCTClinical trialPANSSAMINO-ACID OXIDASESERINE-INDUCED NEPHROTOXICITYPLACEBO-CONTROLLED TRIALDRUG-NAIVE PATIENTMAJOR DEPRESSIONCLINICAL-TRIALSDOUBLE-BLINDSCHIZOPHRENIAINHIBITORBRAIN110399 Clinical Sciences not elsewhere classified920410 Mental HealthFaculty of HealthSchool of MedicineInnovation in Mental and Physical Health and Clinical Treatment3202 Clinical sciences420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC